Literature DB >> 22271597

Rapid conversion of human ESCs into mouse ESC-like pluripotent state by optimizing culture conditions.

Qi Gu1, Jie Hao, Xiao-yang Zhao, Wei Li, Lei Liu, Liu Wang, Zhong-hua Liu, Qi Zhou.   

Abstract

The pluripotent state between human and mouse embryonic stem cells is different. Pluripotent state of human embryonic stem cells (ESCs) is believed to be primed and is similar with that of mouse epiblast stem cells (EpiSCs), which is different from the naïve state of mouse ESCs. Human ESCs could be converted into a naïve state through exogenous expression of defined transcription factors (Hanna et al., 2010). Here we report a rapid conversion of human ESCs to mouse ESC-like naïve states only by modifying the culture conditions. These converted human ESCs, which we called mhESCs (mouse ESC-like human ESCs), have normal karyotype, allow single cell passage, exhibit domed morphology like mouse ESCs and express some pluripotent markers similar with mouse ESCs. Thus the rapid conversion established a naïve pluripotency in human ESCs like mouse ESCs, and provided a new model to study the regulation of pluripotency.

Entities:  

Mesh:

Year:  2012        PMID: 22271597      PMCID: PMC4875221          DOI: 10.1007/s13238-012-2007-8

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  49 in total

1.  Derivation and long-term culture of human parthenogenetic embryonic stem cells using human foreskin feeders.

Authors:  Zhenyu Lu; Wanwan Zhu; Yang Yu; Dan Jin; Yunqian Guan; Ruqiang Yao; Yu Alex Zhang; Yunshan Zhang; Qi Zhou
Journal:  J Assist Reprod Genet       Date:  2010-06       Impact factor: 3.412

2.  Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations.

Authors:  Christopher J Lengner; Alexander A Gimelbrant; Jennifer A Erwin; Albert Wu Cheng; Matthew G Guenther; G Grant Welstead; Raaji Alagappan; Garrett M Frampton; Ping Xu; Julien Muffat; Sandro Santagata; Doug Powers; C Brent Barrett; Richard A Young; Jeannie T Lee; Rudolf Jaenisch; Maisam Mitalipova
Journal:  Cell       Date:  2010-05-13       Impact factor: 41.582

3.  Generation of induced pluripotent stem cells from bovine embryonic fibroblast cells.

Authors:  Xiaoping Han; Jianyong Han; Fangrong Ding; Suying Cao; Seong Soo Lim; Yunping Dai; Ran Zhang; Yurui Zhang; Bing Lim; Ning Li
Journal:  Cell Res       Date:  2011-08-09       Impact factor: 25.617

4.  Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine.

Authors:  Arata Honda; Michiko Hirose; Masanori Hatori; Shogo Matoba; Hiroyuki Miyoshi; Kimiko Inoue; Atsuo Ogura
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

5.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides.

Authors:  A G Smith; J K Heath; D D Donaldson; G G Wong; J Moreau; M Stahl; D Rogers
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

6.  Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells.

Authors:  Petr Dvorak; Dana Dvorakova; Stanislava Koskova; Martina Vodinska; Miroslava Najvirtova; Daniel Krekac; Ales Hampl
Journal:  Stem Cells       Date:  2005-06-13       Impact factor: 6.277

7.  Isolation of epiblast stem cells from preimplantation mouse embryos.

Authors:  Fadi J Najm; Josh G Chenoweth; Philip D Anderson; Joseph H Nadeau; Raymond W Redline; Ronald D G McKay; Paul J Tesar
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

8.  Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors.

Authors:  Lei Bao; Lixiazi He; Jijun Chen; Zhao Wu; Jing Liao; Lingjun Rao; Jiangtao Ren; Hui Li; Hui Zhu; Lei Qian; Yijun Gu; Huimin Dai; Xun Xu; Jinqiu Zhou; Wen Wang; Chun Cui; Lei Xiao
Journal:  Cell Res       Date:  2011-01-11       Impact factor: 25.617

Review 9.  Human parthenogenetic embryonic stem cells: one potential resource for cell therapy.

Authors:  Jie Hao; WanWan Zhu; Chao Sheng; Yang Yu; Qi Zhou
Journal:  Sci China C Life Sci       Date:  2009-07-30

10.  iPS cells produce viable mice through tetraploid complementation.

Authors:  Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-long Guo; Qing-wen Ma; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

View more
  10 in total

1.  Tbx3 and Nr5α2 play important roles in pig pluripotent stem cells.

Authors:  Jianyu Wang; Qi Gu; Jie Hao; Yundan Jia; Binghua Xue; Honghong Jin; Jing Ma; Renyue Wei; Tang Hai; Qingran Kong; Gerelchimeg Bou; Ping Xia; Qi Zhou; Liu Wang; Zhonghua Liu
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

2.  Application Of Small Molecules Favoring Naïve Pluripotency during Human Embryonic Stem Cell Derivation.

Authors:  Margot Van der Jeught; Jasin Taelman; Galbha Duggal; Sabitri Ghimire; Sylvie Lierman; Susana M Chuva de Sousa Lopes; Dieter Deforce; Tom Deroo; Petra De Sutter; Björn Heindryckx
Journal:  Cell Reprogram       Date:  2015-06       Impact factor: 1.987

3.  Cdh2 stabilizes FGFR1 and contributes to primed-state pluripotency in mouse epiblast stem cells.

Authors:  Toshiyuki Takehara; Takeshi Teramura; Yuta Onodera; John Frampton; Kanji Fukuda
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

4.  Derivation and characterization of human embryonic stem cells on human amnion epithelial cells.

Authors:  Dongmei Lai; Yongwei Wang; Jian Sun; Yifei Chen; Ting Li; Yi Wu; Lihe Guo; Chunsheng Wei
Journal:  Sci Rep       Date:  2015-05-07       Impact factor: 4.379

5.  Efficient generation of mouse ESCs-like pig induced pluripotent stem cells.

Authors:  Qi Gu; Jie Hao; Tang Hai; Jianyu Wang; Yundan Jia; Qingran Kong; Juan Wang; Chunjing Feng; Binghua Xue; Bingteng Xie; Shichao Liu; Jinyu Li; Yilong He; Jialu Sun; Lei Liu; Liu Wang; Zhonghua Liu; Qi Zhou
Journal:  Protein Cell       Date:  2014-05       Impact factor: 14.870

Review 6.  RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

Authors:  Juan A Bernal
Journal:  J Cardiovasc Transl Res       Date:  2013-07-13       Impact factor: 4.132

7.  Two decades of embryonic stem cells: a historical overview.

Authors:  C Eguizabal; B Aran; S M Chuva de Sousa Lopes; M Geens; B Heindryckx; S Panula; M Popovic; R Vassena; A Veiga
Journal:  Hum Reprod Open       Date:  2019-01-29

8.  Efficient reprogramming of naïve-like induced pluripotent stem cells from porcine adipose-derived stem cells with a feeder-independent and serum-free system.

Authors:  Yu Zhang; Chao Wei; Pengfei Zhang; Xia Li; Tong Liu; Yong Pu; Yunsheng Li; Zubing Cao; Hongguo Cao; Ya Liu; Xiaorong Zhang; Yunhai Zhang
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

9.  Generation of induced pluripotent stem cells with high efficiency from human umbilical cord blood mononuclear cells.

Authors:  Juan Wang; Qi Gu; Jie Hao; Donghui Bai; Lei Liu; Xiaoyang Zhao; Zhonghua Liu; Liu Wang; Qi Zhou
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-09-28       Impact factor: 7.691

10.  CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells.

Authors:  Eva Z Jacobs; Sharat Warrier; Pieter-Jan Volders; Eva D'haene; Eva Van Lombergen; Lies Vantomme; Margot Van der Jeught; Björn Heindryckx; Björn Menten; Sarah Vergult
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.